Annals of Oncology Advance Access published online on June 2, 2006
Annals of Oncology, doi:10.1093/annonc/mdl152
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 From the American Society of Clinical Oncology, Alexandria, VA; and the European Society for Medical Oncology, Viganello-Lugano, Switzerland
* To whom correspondence should be addressed.
Received May 10, 2006
Accepted May 16, 2006
special article
ASCO-ESMO consensus statement on quality cancer care
ASCO 1 *
ASCO, E-mail: international{at}asco.org
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
On behalf of ESMO and J. Baselga Creating a stronger front against cancer: ESMO and ECCO join forces Ann. Onc., August 1, 2008; 19(8): 1367 - 1368. [Full Text] [PDF] |
||||
![]() |
P. G. Casali and On behalf of the Executive Committee of ESMO The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO) Ann. Onc., December 1, 2007; 18(12): 1923 - 1925. [Full Text] [PDF] |
||||
![]() |
E Bajetta, A Gevorgyan, and H Mellstedt National integration of European standards Ann. Onc., June 1, 2007; 18(6): 969 - 970. [Full Text] [PDF] |
||||
E-letters:
Read all E-letters
- Response to ASCO-ESMO Consensus Statement on Quality Cancer Care
- Barry R Goldspiel, et al.
- Annals of Oncology, 11 Aug 2006 [Full text]
